Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort

Blood blood.2024025834.

https://doi.org/10.1182/blood.2024025834

Published: 2024

Includes: Supplemental data

Journal Articles

Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age

Ioannis Mantzaris, Mendel Goldfinger, Nishi Shah, Annemarie Munoz, Aradhika Dhawan, Nicole Chambers, Karen Fehn, Joel Victor, Aditi Shastri, Kira Gritsman, Noah Kornblum, Alejandro Sica, Dennis L Cooper, Amit Verma, Mimi Kim, Ulrich Steidl, Eric J Feldman, Marina Y. Konopleva

Blood (2023) 142 (Supplement 1): 4257.

https://doi.org/10.1182/blood-2023-188176

Published: 2023

Journal Articles

Comparison of the Prognostic Performance of European Leukemianet 2017 and 2022 Classifications in a Minority-Rich Population of Adult Patients with Acute Myeloid Leukemia

Kateryna Fedorov, Alexander Sisto, Josette Kamel, Mark Forsberg, Kith Pradhan, Nishi Shah, Aditi Shastri, Mendel Goldfinger, Noah Kornblum, Alejandro Sica, Dennis L Cooper, Kira Gritsman, Amit K. Verma, Eric J Feldman, Marina Y. Konopleva, Ioannis Mantzaris

Blood (2023) 142 (Supplement 1): 2968.

https://doi.org/10.1182/blood-2023-180856

Published: 2023

Journal Articles

Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population

Lauren Laufer, Lemchukwu Amaeshi, Alex Sisto, Kateryna Fedorov, Rosmi Mathew, David Levitz, Ioannis Mantzaris, Noah Kornblum, Mendel Goldfinger, Alejandro Sica, Dennis L Cooper, Marina Y. Konopleva, Bruce Rapkin, Amit Verma, Aditi Shastri, Nishi Shah

Blood (2023) 142 (Supplement 1): 2350.

https://doi.org/10.1182/blood-2023-186867

Published: 2023

Journal Articles

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Blood (2023) 142 (Supplement 1): 545.

https://doi.org/10.1182/blood-2023-174875

Published: 2023

Journal Articles

Clinical Characteristics of Light Chain Amyloidosis in an Underserved Patient Population

Nina Samuel, Nishi Shah

Blood (2023) 142 (Supplement 1): 6758.

https://doi.org/10.1182/blood-2023-190458

Published: 2023

Journal Articles

Exposure to Fine Particulate Matter (PM2.5) Is Associated with Worse Multiple Myeloma Outcomes in a Large, Urban, Multi-Ethnic Cohort

Michael Wysota, Sarah Jacobs, Kith Pradhan, Joel Rosiene, Charles Hall, George Downward, Yocheved Halberstam, Nishi Shah, Dean Hosgood, Aditi Shastri

Blood (2023) 142 (Supplement 1): 531.

https://doi.org/10.1182/blood-2023-186937

Published: 2023

Journal Articles

Effective and Safe Molecular-Pharmacodynamic Once Weekly Dosing of Decitabine and Venetoclax Is a Highly Effective and Well-Tolerated Induction Therapy for AML: Interim Results of a Phase 2 Trial

Blood (2023) 142 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2023-185379

Published: 2023

Journal Articles

Efficacy of Bispecific Antibodies Vs CAR-T in the Treatment of Extramedullary Disease and High-Risk Cytogenetics in Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis

Charan Thej Reddy Vegivinti, Jaison Lawrence Alexander Santhi, Lawrence Liu, Praneeth Reddy Keesari, Rahul Thakur, M Bakri Hammami, Venkatesh Kapu, Sindhu Pericherla, Murali Mohan reddy Gopireddy, Nagarathna Poojary, Ananta Ghimire, Nishi Shah, Murali Janakiram

Blood (2023) 142 (Supplement 1): 1994.

https://doi.org/10.1182/blood-2023-190019

Published: 2023

Journal Articles

Adverse Effects and Non-Relapse Mortality of BCMA-Directed Immunotherapies : An FDA Adverse Event Reporting System (FAERS) Database Study

Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Radhakrishnan, Rajshekhar Chakraborty, Carolina Schinke, Anita D'Souza, Meera Mohan

Blood (2023) 142 (Supplement 1): 358.

https://doi.org/10.1182/blood-2023-182695

Published: 2023

Journal Articles

A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx

Lemchukwu Amaeshi, Alex Sisto, Lauren Laufer, Kateryna Fedorov, Rosmi Mathew, David Levitz, Ioannis Mantzaris, Noah Kornblum, Mendel Goldfinger, Alejandro Sica, Dennis L Cooper, Marina Y. Konopleva, Bruce Rapkin, Amit Verma, Aditi Shastri, Nishi Shah

Blood (2023) 142 (Supplement 1): 7397.

https://doi.org/10.1182/blood-2023-188024

Published: 2023

Journal Articles

Assessing Epidemiological Differences in Myelofibrosis: A Comparative Study of a Single-Center Cohort and the SEER National Database

John Yan, John X Wei, Amit Verma, Nishi Shah, Swati Goel

Blood (2023) 142 (Supplement 1): 7426.

https://doi.org/10.1182/blood-2023-184932

Published: 2023

Journal Articles

High PD-L1 Expression May be Associated with Worse Overall Prognosis in Acute Myeloid Leukemia

Josette M Kamel, Mendel Goldfinger, Jiani Chai, Jui Choudhuri, Marina Y. Konopleva, Eric J Feldman, Ioannis Mantzaris, Dennis L Cooper, Aditi Shastri, Nishi Shah, Noah Kornblum, Kira Gritsman, Alejandro Sica, Yanhua Wang, Xuejun Tian, Amit Verma, Swati Goel

Blood (2023) 142 (Supplement 1): 6050.

https://doi.org/10.1182/blood-2023-188243

Published: 2023

Journal Articles

Oncogenic JAK2/STAT Signaling Molecules Activation Is Associated with PD-L1 Upregulation in Acute Myeloid Leukemia

Jiani Chai, Jui Choudhuri, Qing Wang, Yanan Fang, Yang Shi, Wa Shen, Swati Goel, Ioannis Mantzaris, Aditi Shastri, R. Alejandro Sica, Nishi Shah, Kira Gritsman, Marina Konopleva, Noah Kornblum, Amit Verma, Mendel Goldfinger, Yanhua Wang, Xuejun Tian

Blood (2022) 140 (Supplement 1): 6256–6257.

https://doi.org/10.1182/blood-2022-162857

Published: 2022

Journal Articles

Barriers to Autologous Stem Cell Transplantation As Consolidation for Primary Central Nervous System Lymphoma (PCNSL) in HIV Positive Patients in a Minority Rich Cohort in the Bronx, New York

Hiba Narvel, Sindhu Vikash, Charan Thej Reddy Vegivinti, Abdul-Hamid Bazarbachi, M Bakri Hammami, Ansh Krishnachandra Mehta, Daniel K. Reef, Adnan Narvel, Riya Patel, Aditi Shastri, Noah Kornblum, Ioannis Mantzaris, Marina Konopleva, Dennis Cooper, Nishi Shah, Mendel Goldfinger, Ira Braunschweig, Amit Verma, R. Alejandro Sica

Blood (2022) 140 (Supplement 1): 13204–13205.

https://doi.org/10.1182/blood-2022-165704

Published: 2022

Journal Articles

Trends in Collection and Utilization of Autologous Hematopoietic Stem Cells (APBHC) Intended for Transplant in Patients with Multiple Myeloma

Nina Samuel, Lauren Laufer, Rodrigo Tanaguchi, Joel Rosiene, Carlo Palesi, Richard Elkind, Ioannis Mantzaris, Aditi Shastri, Noah Kornblum, R. Alejandro Sica, Urvi A Shah, Dennis Cooper, Amit Verma, Nishi Shah

Blood (2022) 140 (Supplement 1): 7936–7938.

https://doi.org/10.1182/blood-2022-169443

Published: 2022

Journal Articles

Evaluation of CNS Involvement in Secondary AML: Incidence and Impact on Outcome

Blood (2022) 140 (Supplement 1): 11653–11655.

https://doi.org/10.1182/blood-2022-158112

Published: 2022

Journal Articles

Pre-Conditioning Easix Is Associated with Survival after Autologous Hematopoietic Stem Cell Transplant in Mature T-Cell Lymphomas

Blood (2022) 140 (Supplement 1): 12928–12929.

https://doi.org/10.1182/blood-2022-170810

Published: 2022

Journal Articles

A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses

John X Wei, Nina Samuel, Richard Elkind, Carlo Palesi, Aditi Shastri, R. Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Kira Gritsman, Amit Verma, Mendel Goldfinger, Dennis Cooper, Nishi Shah

Blood (2022) 140 (Supplement 1): 12890–12891.

https://doi.org/10.1182/blood-2022-166689

Published: 2022

Journal Articles

Outcomes of Autologous Stem Cell Transplantation for Relapsed DLBCL in Single Center Serving a Minority Population

Blood (2022) 140 (Supplement 1): 13225–13227.

https://doi.org/10.1182/blood-2022-170633

Published: 2022

NARROW

A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort

Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age

Comparison of the Prognostic Performance of European Leukemianet 2017 and 2022 Classifications in a Minority-Rich Population of Adult Patients with Acute Myeloid Leukemia

Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Clinical Characteristics of Light Chain Amyloidosis in an Underserved Patient Population

Exposure to Fine Particulate Matter (PM2.5) Is Associated with Worse Multiple Myeloma Outcomes in a Large, Urban, Multi-Ethnic Cohort

Effective and Safe Molecular-Pharmacodynamic Once Weekly Dosing of Decitabine and Venetoclax Is a Highly Effective and Well-Tolerated Induction Therapy for AML: Interim Results of a Phase 2 Trial

Efficacy of Bispecific Antibodies Vs CAR-T in the Treatment of Extramedullary Disease and High-Risk Cytogenetics in Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis

Adverse Effects and Non-Relapse Mortality of BCMA-Directed Immunotherapies : An FDA Adverse Event Reporting System (FAERS) Database Study

A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx

Assessing Epidemiological Differences in Myelofibrosis: A Comparative Study of a Single-Center Cohort and the SEER National Database

High PD-L1 Expression May be Associated with Worse Overall Prognosis in Acute Myeloid Leukemia

Oncogenic JAK2/STAT Signaling Molecules Activation Is Associated with PD-L1 Upregulation in Acute Myeloid Leukemia

Barriers to Autologous Stem Cell Transplantation As Consolidation for Primary Central Nervous System Lymphoma (PCNSL) in HIV Positive Patients in a Minority Rich Cohort in the Bronx, New York

Trends in Collection and Utilization of Autologous Hematopoietic Stem Cells (APBHC) Intended for Transplant in Patients with Multiple Myeloma

Evaluation of CNS Involvement in Secondary AML: Incidence and Impact on Outcome

Pre-Conditioning Easix Is Associated with Survival after Autologous Hematopoietic Stem Cell Transplant in Mature T-Cell Lymphomas

A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses

Outcomes of Autologous Stem Cell Transplantation for Relapsed DLBCL in Single Center Serving a Minority Population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only